glp-1 and parkinson's disease Glucagon-like peptide-1 (GLP-1) receptor agonists neuroinflammation: Implications for neurodegenerative treatment GLP-1 Receptor Agonists: A New

Every vial that sits punctured but partially used is on a 28-day countdown regardless of the original BUD, so managing your inventory to minimize waste is an important part of cost-effective peptide research

A separate 72-week trial found that obese or overweight patients using Mounjaro, the most effective weight loss injection available, lost between 15% and 20% of their body weight

Ginger Vieira, author, speaker, podcast host, and type 1 diabetes advocate, has shared her personal experience with microdosing semaglutide as part of her diabetes management plan

If you are already managing diabetes with metformin, insulin, or an SGLT2 inhibitor, and your doctor has now mentioned Ozempic for type 2 diabetes or Rybelsus, Mounjaro, or one of the new generic semaglutide injections you are not alone, and you deserve a clear, honest answer about what happens next

PlexusDx eliminates intermediariesno pharmacy benefit managers, no insurer markup, no prior-authorization delays

April 1, 2026: Lawsuits Involving Ozempic & Other GLP-1s Climb to Over 3,500 Ozempics manufacturer, Novo Nordisk, and one other GLP-1 company are facing about 3,546 lawsuits in an active, federally consolidated MDL filed by former patients and their loved ones